The introduction of nicotinamide like a nicotine substitute in e-cigarette and smokeless products and solutions signifies an important regulatory challenge for the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is thought to work as a sedative at high dosages6. The claims cr